-
公开(公告)号:US07256198B2
公开(公告)日:2007-08-14
申请号:US11061144
申请日:2005-02-18
申请人: Paul Jeffrey Dollings , Arlene Joan Dietrich , Lisa Marie Havran , Chae-Koo Dan Chong , Donna Mary Huryn , Albert Jean Robichaud , Boyd Lynn Harrison , Wayne Everett Childers , Alexander A. Greenfield , James Jacob Bicksler , Vasilios Marathias
发明人: Paul Jeffrey Dollings , Arlene Joan Dietrich , Lisa Marie Havran , Chae-Koo Dan Chong , Donna Mary Huryn , Albert Jean Robichaud , Boyd Lynn Harrison , Wayne Everett Childers , Alexander A. Greenfield , James Jacob Bicksler , Vasilios Marathias
IPC分类号: A01N43/54 , A61K31/505 , C07D239/00 , C07D239/70 , C07D471/00 , C07D487/00
CPC分类号: C07D487/04 , C07D487/10
摘要: Novel pyrimidoindolone compounds are disclosed. Methods of using the pyrimidoindolone compounds and compositions containing the compounds in the treatment and/or prevention of disease and other conditions related to inflammation, neurodegeneration, osteoarthritis and apoptosis are also disclosed.
摘要翻译: 公开了新的嘧啶吲哚酮化合物。 还公开了使用嘧啶吲哚酮酮化合物和含有该化合物的组合物在治疗和/或预防与炎症,神经变性,骨关节炎和细胞凋亡相关的疾病和其它病状的方法。
-
42.
公开(公告)号:US07238696B2
公开(公告)日:2007-07-03
申请号:US10778427
申请日:2004-02-13
IPC分类号: A61K31/496 , C07D403/04 , C07D409/14
CPC分类号: C07D231/56 , C07D403/04 , C07D409/04 , C07D409/12
摘要: The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of disorders related to or affected by the 5-HT6 receptor
摘要翻译: 本发明提供式I化合物及其用于治疗与5-HT 6受体有关或受其影响的病症的用途
-